Liquidia prices $50M IPO

Liquidia Technologies Inc. (NASDAQ:LQDA) added $0.10 to $11.10 on Thursday after raising $50 million through the sale of 4.5 million shares at $11 in an IPO underwritten by Jefferies, Cowen, Needham and Wedbush PacGrow. Liquidia priced the offering at the middle of its proposed range of $10-$12. The price valued Liquidia at $166.3 million.

Liquidia is developing therapeutics based on its PRINT particle engineering technology. It is conducting the Phase III INSPIRE trial of lead program LIQ861 to treat pulmonary arterial hypertension (PAH). LIQ861 is a powder formulation of treprostinil delivered via dry powder inhaler...